Polen Capital Management Reduces $148M in IDEXX Laboratories, Inc. ($IDXX)
Key Points
- Polen Capital Management changed its IDEXX Laboratories, Inc. ($IDXX) stake by 27.6% last quarter, cutting to 695,811 shares worth $390.27 million.
- Wall Street's consensus rating on $IDXX is Buy and an average price target of $709.14.
- $IDXX last traded around $560.88.
Polen Capital Management reduced its position in IDEXX Laboratories, Inc. ($IDXX) by 27.6% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 695,811 shares of IDEXX Laboratories, Inc. after selling 264,726 shares during the quarter. Polen Capital Management's holdings in IDEXX Laboratories, Inc. were worth $390.27 million as of its most recent filing.
IDEXX Laboratories, Inc. ($IDXX) Stock
IDEXX Laboratories, Inc. Earnings
Analysts Set New Price Targets
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.